SCHEMBL653885

SCHEMBL653885

OC1CCCCCCCC1

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.91
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 1/20 0.35
EPHX1 P07099 5/20 0.33
CYP3A4 P08684 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
KDM4E B2RXH2 1/20 0.33
EPHX2 P34913 1/20 0.33
ESR2 Q92731 1/20 0.33
MGLL Q99685 1/20 0.33
GPR119 Q8TDV5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11948880 1.00 TSHR (0.91) TSHRCES2CES1CA1CA2
SCHEMBL2193805 1.00 TSHR (0.91) TSHRCES2CES1CA1CA2
SCHEMBL811883 1.00 TSHR (0.91) TSHRCES2CES1CA1CA2
SCHEMBL2197408 1.00 TSHR (0.91) TSHRCES2CES1CA1CA2
Cyclooctanol SCHEMBL8732936 1.00 TSHR (0.91) TSHRCES2CES1CA1CA2
SCHEMBL11948482 1.00 TSHR (0.91) TSHRCES2CES1CA1CA2
SCHEMBL23121456 1.00 TSHR (0.91) TSHRCES2CES1CA1CA2
Cyclooctanol SCHEMBL40903 1.00
Cyclohexanol SCHEMBL8503956 1.00 TSHR (0.91) TSHRCES2CES1CA1CA2
Cyclohexanol SCHEMBL5545 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 490 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115160127-B Method for preparing long carbon chain dibasic acid through co-oxidation reaction 中国天辰工程有限公司 2024-06-11 CN claimed
CN-117983300-A Catalyst containing N-triptycene ligand for ethylene selective tetramerization and preparation method and application thereof 华东理工大学 2024-05-07 CN claimed
CN-115160127-A Method for preparing long carbon chain dibasic acid through co-oxidation reaction 中国天辰工程有限公司 2022-10-11 CN claimed
US-20260132049-A1 METHOD FOR PRODUCING IRON OXIDE MAGNETIC PARTICLES, AND IRON OXIDE MAGNETIC PARTICLES FORMED THEREFROM ZTI BIOSCIENCES CO LTD (KR) 2026-05-14 US disclosed
US-20260078271-A1 AQUEOUS-INKJET PIGMENT DISPERSION AND METHOD FOR MANUFACTURING THE SAME SANYO COLOR WORKS (JP) 2026-03-19 US disclosed
EP-4711425-A2 AQUEOUS-INKJET PIGMENT DISPERSION AND METHOD FOR MANUFACTURING THE SAME Sanyo Color Works, Ltd. (JP) 2026-03-18 EP disclosed
US-20250361405-A1 COMPOSITION BASED ON A POLYMERIZABLE COMPONENT AND A THIXOTROPIC ADDITIVE ARKEMA FRANCE (FR) 2025-11-27 US disclosed
EP-4543946-A1 METHOD FOR PREPARING ZIEGLER-NATTA CATALYST FOR POLYMERIZATION OF LOW-DENSITY COPOLYMER SK Innovation Co., Ltd. (KR) 2025-04-30 EP disclosed
EP-4536751-A1 COMPOSITION BASED ON A POLYMERIZABLE COMPONENT AND A THIXOTROPIC ADDITIVE ARKEMA FRANCE (FR) 2025-04-16 EP disclosed
WO-2025041708-A1 METHOD FOR MANUFACTURING SUBSTRATE WITH ANTIREFLECTION FILM, AND SUBSTRATE WITH ANTIREFLECTION FILM 日産化学株式会社 2025-02-27 WO disclosed
WO-2025041710-A1 METHOD FOR MANUFACTURING ANTIREFLECTION FILM-BEARING SUBSTRATE, AND ANTIREFLECTION FILM-BEARING SUBSTRATE 日産化学株式会社 2025-02-27 WO disclosed
US-4992493-A Heat, oxidation resistance; photostability CIBA-GEIGY CORPORATION (US) 1991-02-12 US disclosed
EP-0163433-B1 ANTIBACTERIAL SOLID COMPOSITION FOR ORAL ADMINISTATION Takeda Chemical Industries, Ltd. (JP) 1990-08-01 EP disclosed
US-4883870-A IMPROVING HEAT, LIGHT AND OXIDATION RESISTANCE OF POLYMERS CIBA-GEIGY CORPORATION (US) 1989-11-28 US disclosed
US-4859724-A Bicyclic piperidine compounds for use as stabilizers for organic materials CIBA-GEIGY CORPORATION (US) 1989-08-22 US disclosed
EP-0299925-A1 Piperidine-triazine compounds for use as stabilizers for organic materials CIBA-GEIGY AG (CH) 1989-01-18 EP disclosed
EP-0294329-A2 Bicyclic piperidine compounds for use as stabilizers for organic materials CIBA-GEIGY AG (CH) 1988-12-07 EP disclosed
EP-0290393-A2 Piperidine compounds for use as light stabilizers, heat stabilizers and oxidation stabilizers for organic materials CIBA-GEIGY AG (CH) 1988-11-09 EP disclosed
US-4616008-A LIPID-SOLUBLE CEPHALOSPORINS AND CYCLODEXTRINS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1986-10-07 US disclosed
EP-0163433-A2 Antibacterial solid composition for oral administation Takeda Chemical Industries, Ltd. (JP) 1985-12-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132049-A1 METHOD FOR PRODUCING IRON OXIDE MAGNETIC PARTICLES, AND IRON OXIDE MAGNETIC PARTICLES FORMED THEREFROM FASN, AIFM2, SFXN1 TSHR 1967/4885CES2 1985/4885CES1 1400/4885
US-20260078271-A1 AQUEOUS-INKJET PIGMENT DISPERSION AND METHOD FOR MANUFACTURING THE SAME ADH1A, PRPH, TYR TSHR 4382/4885CES2 4702/4885CES1 4782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.